NewAmsterdam Pharma Company N.V. Share Price BOERSE MUENCHEN
Equities
KH6
NL00150012L7
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
After market 01:30:01 am | |||
18.1 EUR | 0.00% |
|
17.95 | -0.83% |
Sales 2024 * | 86.38L 92.52L 77Cr | Sales 2025 * | 63.11L 67.6L 56Cr | Capitalization | 164.1Cr 175.78Cr 15TCr |
---|---|---|---|---|---|
Net income 2024 * | -21Cr -22Cr -1.87TCr | Net income 2025 * | -14Cr -15Cr -1.24TCr | EV / Sales 2024 * | 190 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 260 x |
P/E ratio 2024 * |
-7.67
x | P/E ratio 2025 * |
-11.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.29% |
Latest transcript on NewAmsterdam Pharma Company N.V.
1 week | +11.73% | ||
Current month | +5.85% | ||
1 month | +4.02% | ||
3 months | -13.81% |
![Extreme 16.1](/images/extremecours_fleche.png)
![Extreme 15.9](/images/extremecours_fleche.png)
Date | Price | Change |
---|---|---|
29/24/29 | 18.1 | 0.00% |
27/24/27 | 18.1 | -1.63% |
26/24/26 | 18.4 | +0.55% |
25/24/25 | 18.3 | 0.00% |
24/24/24 | 18.3 | +8.93% |
Real-time BOERSE MUENCHEN, June 29, 2024 at 01:13 am IST
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.20% | 12TCr | |
+19.67% | 11TCr | |
+18.95% | 2.65TCr | |
-23.86% | 1.94TCr | |
-19.03% | 1.62TCr | |
-20.90% | 1.54TCr | |
-46.14% | 1.52TCr | |
+63.85% | 1.49TCr | |
+4.49% | 1.35TCr |
- Stock Market
- Equities
- NAMS Stock
- KH6 Stock